Wednesday, July 2, 2025
Newsletter
Pricing Plans
All

Tag: Eli Lilly and Co
E

spot_img

Novo Nordisk’s diabetes drug Ozempic may lower the risk of opioid overdoses, study says

Business Madconsole -

Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices

Business Madconsole -

FTC sues drug middlemen for allegedly inflating insulin prices

Business Madconsole -

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

Business Madconsole -

Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply

Business Madconsole -

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

Business Madconsole -

White House says negotiated prices for Medicare drugs will save U.S. $6 billion, beneficiaries $1.5 billion in first year

Business Madconsole -

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

Business Madconsole -

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

Business Madconsole -

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

Business Madconsole -

Eli Lilly’s weight loss drug Zepbound cuts heart failure risks in late-stage study

Business Madconsole -

Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says

Business Madconsole -
Load more

About us

Welcome to the ultimate destination for all things motorsports, gaming, and technology! We are thrilled to have you here. Our website is your go-to source for the latest news, insightful analysis, and exciting updates in these dynamic fields.

Latest Articles

Most Popular

Subscribe

© MADCONSOLE. All Rights Reserved.

Mastodon